RedHill Biopharma Ltd (RDHL)

[scottsmith]

Too bad about cydy. I've been watching that for a while. When it didn't go up after fda reduced trial participants dramatically several months ago, I sold.

Rdhl has about 15% tute ownership and about 40% insider ownership. That's not bad for an Israeli microcap. In my opinion the major issue is that they've had no game-changing catalyst in a looooong time. Since then, people move on and the company faced severe dilution. Fortunately, rdhl has two game changers in the next 6-10 weeks. If both those readouts are positive, I expect to see 200 percent from here.